Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease

Manuscript Number: 

21-5567R3

Author(s): 
Jean C. Augustinack, Samantha Champion, Bruce Fischl, Matthew P. Frosch, Douglas N. Greve, Melanie Lang-Orsini, Josué Llamas-Rodríguez, Jan Oltmer, Natalya Slepneva, Ruopeng Wang, Emily Williams, André J.W. van der Kouwe

Disclosures

Jean C. Augustinack

  • Nothing to Disclose

Samantha Champion

  • Nothing to Disclose

Bruce Fischl

  • Equity:
    I am part owner of CorticoMetrics, a small LLC commercializing neuroimaging analysis tools for use in clinical applications

Matthew P. Frosch

  • Grants
    • Agency: 
      Biogen
      Dates: 
      9/2016-9/2026
    • Agency: 
      Voyager Therapeutics
      Dates: 
      1/2020-1/2025

Douglas N. Greve

  • Nothing to Disclose

Melanie Lang-Orsini

  • Nothing to Disclose

Josué Llamas-Rodríguez

  • Nothing to Disclose

Jan Oltmer

  • Nothing to Disclose

Natalya Slepneva

  • Nothing to Disclose

André J.W. van der Kouwe

  • Consulting Fees:
    Medical Advisory Board of Nous Imaging, Inc., $400/meeting, two or more meetings per year. Consulting for Nous Imaging, $300/month. The business of Nous Imaging does not relate to the subject matter of this paper.
    Equity:
    Unexercised stock options in Nous Imaging, Inc.
    Patents/Royalties
    I have patents related to MRI methods. They are not licensed and do not relate to the subject matter of this paper.

Ruopeng Wang

  • Nothing to Disclose

Emily Williams

  • Nothing to Disclose